| Date | Title | Description |
| 27.05.2026 | Domestic Display Chip Leader Viewtrix Technology Listed on Hong Kong Stock Exchange | SHANGHAI, May 27, 2026 /PRNewswire/ -- Viewtrix Technology, a portfolio company of Qiming Venture Partners and a leading display chip design enterprise in China, successfully listed on the Hong Kong Stock Exchange, marking the sixth IPO for... |
| 03.03.2026 | Diversity will define the next era of biotech infrastructure | - |
| 11.02.2026 | Chinese Edge AI Chip Leader Axera Lists on Hong Kong Stock Exchange | SHANGHAI, Feb. 11, 2026 /PRNewswire/ -- Axera, a portfolio company of Qiming Venture Partners and a leading Chinese edge AI chip company, successfully listed on the Hong Kong Stock Exchange on February 10th, 2026, Beijing time, becoming the... |
| 16.01.2026 | Daily Tech Insider Unpacks AI Assistants’ Leap From Code to Chores | Image: Generated via Google’s Nano Banana
If you tracked the headlines this week, you noticed a pattern: Daily Tech Insider started reading like a help-wanted board for mechanized minions.
Google flung open Gemini’s vault so it can comb you... |
| 09.01.2026 | Schrodinger to offer Eli Lilly's AI drug discovery platform on its software | Jan 9 : Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, on its drug designing software.
Integration of Lilly's TuneLab into Schrodinger's LiveDesign will give bio... |
| 02.01.2026 | Domestic GPU Leader Biren Technology Listed on Hong Kong Stock Exchange | SHANGHAI, Jan. 2, 2026 /PRNewswire/ -- Qiming Venture Partners' portfolio company Biren Technology, a leading domestic GPU developer, successfully listed on the Hong Kong Stock Exchange today, becoming the first company to go public in Hong... |
| 19.12.2025 | The rise and impact of AI in Biotechnology and Healthcare | - |
| 30.11.2025 | Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery | SHANGHAI, Nov. 30, 2025 /PRNewswire/ -- On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings in Wang Fuk Court in Tai Po, Hong Kong, causing severe casualties and drawing widespread public conce... |
| 16.10.2025 | Qiming Venture Partners' Portfolio Company Yunji Technology Successfully Lists on the Hong Kong Stock Exchange | SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Yunji Technology, a global leader in the hospitality robotic-based AI agents market and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock Exchange on Octo... |
| 22.09.2025 | Quantum Computing in Drug Discovery: Why Are We Still Waiting? | Share
Share
Share
Share
Email
Quantum computing is no longer theoretical—algorithms like VQE and QAOA exist, hardware is advancing, and the potential to revolutionize medicine is undeniable. Yet, where are the breakthroughs in curing diseas... |
| 21.09.2025 | Lazard Hires Geoffrey Porges to Healthcare Advisory Group | Lazard has announced that Dr. Geoffrey Porges has joined the firm as a Managing Director within its Healthcare Advisory Group, where he will advise on transactions across the diversified biopharmaceutical sector. This appointment brings a s... |
| 02.09.2025 | AI-driven drug discovery picks up as FDA pushes to reduce animal testing | Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near future.
Within the next three to five years, using ... |
| 30.06.2025 | Qiming Venture Partners' Portfolio Company Unisound Successfully Lists on the Hong Kong Stock Exchange | SHANGHAI, June 30, 2025 /PRNewswire/ -- On June 30th, Beijing time, Unisound, a pioneer in the industrialization of AI technologies in China and a portfolio company of Qiming Venture Partners, has successfully debuted on the Hong Kong Stock... |
| 24.02.2025 | Greek Co-Founded Achira Secures €31.54M with NVIDIA’s Backing | Company:
Greek co-founded Achira, a startup combining AI and physics-based methods for drug discovery, secured a €31.54 million seed round from Dimension, Amplify Partners, Compound, and NVentures (NVIDIA’s VC arm).
👯 Founders: John Chodera... |
| 27.01.2025 | Qiming Venture Partners' Portfolio Company HyperStrong Successfully Listed on STAR Market | SHANGHAI, Jan. 27, 2025 /PRNewswire/ -- On January 27th, 2025, Beijing Time, Qiming Venture Partners' portfolio company HyperStrong, a leading provider of battery energy storage systems (BESS) in China, successfully debuted on the Shanghai ... |
| 24.12.2024 | Prequel: $3.3 Million (Seed) Secured For Helping Enterprises Boost Application Reliability | Prequel, a community-driven problem detection and management platform for cloud applications, announced it emerged from stealth and raised $3.3 million in seed funding. The round was led by Work-Bench, with participation from Runtime Ventur... |
| 18.12.2024 | Prequel's Bold Leap: A New Era in Application Reliability | In the fast-paced world of cloud applications, reliability is king. Enter Prequel, a new player that just raised $3.3 million in seed funding. This community-driven platform aims to revolutionize how enterprises detect and manage problems i... |
| 16.12.2024 | Prequel raises $3.3M to help enterprises boost application reliability by synthesizing global failure and problem detection knowledge; emerges from stealth | Prequel Logo
Prequel, the community-driven problem detection and management platform for cloud applications, has emerged from stealth with $3.3 million in seed funding led by Work-Bench. Notable founders, including Shay Banon of Elastic, pa... |
| 05.06.2024 | Qiming's Nisa Leung Made the 2024 Forbes Midas List | SHANGHAI, June 4, 2024 /PRNewswire/ -- The 2024 Forbes Midas List, a distinguished industry list of the world's best venture capital investors, has been unveiled. Nisa Leung, Managing Partner at Qiming Venture Partners, has become a Forbes ... |
| 06.07.2022 | How does Schrödinger make money? | The company makes the majority of its revenue from fees for the use of its software
The cost of drug development is incredibly high: a study published in JAMA Network found that the estimated median capitalized research and development cost... |
| 27.12.2021 | Healthtech stocks are ending 2021 on a down note | Nearly all of the companies that went public over the last 2 years have lost value since October
A couple of months ago, I wrote about all the healthtech companies that had gone public over the last couple of years, taking advantage of a nu... |
| 11.11.2021 | Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update - Form 8-K | Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update
Third Quarter Total Revenue of $29.9 Million, Up 16 Percent Year-Over-Year; Software Revenue of $24.3 Million
Recent Collaboration with Centessa Pharmaceut... |
| 07.10.2021 | Schrödinger teams up with MD Anderson on WEE1 inhibitor program; Amid JAK safety concerns, AbbVie touts new data for Rinvoq | Physics-based discovery outfit Schrödinger and the University of Texas MD Anderson Cancer Center announced today a two-year research collaboration — focused on accelerating and optimizing development of Schröding... |
| 07.10.2021 | More healthtech companies are going public, but are they measuring up? | A number of 2021 healthtech companies are trading below their IPO price, with reduced market caps
Earlier this year I wrote a piece entitled, "A maturing space buoyed by the pandemic: 2021 will be the year of the healthtech IPO." ... |
| 12.08.2021 | Schrödinger : Second Quarter Total Revenue of $29.8 Million, Up 29 Percent Year-Over-Year; Software Revenue of $24.1 Million, Up 15 Percent Year-Over-Year; Company Maintains Full-Year 2021 Financial O... | Second Quarter Total Revenue of $29.8 Million, Up 29 Percent Year-Over-Year; Software Revenue of $24.1 Million, Up 15 Percent Year-Over-Year; Company Maintains Full-Year 2021 Financial Outlook
New Drug Discovery, Co-Development and Co-Comme... |
| 09.04.2021 | Seattle-based Remiges Ventures to launch incubator after heavy investment from Japan; Schrödinger signs lease on new home in Manhattan | After closing $95 million in funding, Remiges Ventures has announced the launch of RDiscovery, a life sciences incubator to advance early-stage therapeutics.
RDiscovery will operate as a subsidiary of Remiges Ventures... |
| 17.03.2021 | Schrödinger to Participate in Credit Suisse 2021 Healthcare Innovators Series: The Intersection of Drug Discovery, Drug Development and Artificial Intelligence | NEW YORK--(BUSINESS WIRE)--Mar 17, 2021--
Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that Ramy Farid, Ph.D., chief executive officer a... |
| 10.03.2021 | Schrödinger Announces Preclinical Data for CDC7 Program to Be Presented at AACR Virtual Annual Meeting 2021 | NEW YORK--(BUSINESS WIRE)--Mar 10, 2021--
Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that preclinical data from its CDC7 program will ... |
| 04.03.2021 | Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2020 and Provides Outlook for 2021 | NEW YORK--(BUSINESS WIRE)--Mar 4, 2021--
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced financial results for the fourth quarter and... |
| 25.02.2021 | Schrödinger Expands Agreement with Google Cloud to Further Bolster Its Drug Discovery and Materials Science Initiatives | NEW YORK--(BUSINESS WIRE)--Feb 25, 2021--
Schrödinger, Inc. (Nasdaq: SDGR) today announced it has expanded its collaboration with Google Cloud to further increase the speed and capacity of its physics-based computational platform for drug d... |
| 25.02.2021 | Xencor, UCLA to partner for new therapeutic antibodies; Schrödinger expands partnership with Google Cloud | Seeking to build on the 20 clinical-stage drug candidates already in its pipeline, California oncology and autoimmune disease-focused biotech Xencor announced on Thursday a partnership with nearby UCLA and the univer... |
| 21.02.2021 | Билл Гейтс пересмотрел свой инвестпортфель: Alibaba и Uber более не интересны | Согласно информации, поданной в Комиссию по ценным бумагам и биржам США, помимо бумаг Alibaba и Uber инвестпортфель Гейтса также лишился активов фонда недвижимости Boston Properties.
Так, например, при продаже пакета депозитарных расписок A... |
| 08.05.2020 | Ex-AstraZeneca exec Kristen Buck hops aboard Icon as CMO; Immunocore taps Brian DiDonato as CFO | Kristen Buck
→ Prominent CRO player Icon is bolstering its leadership, with Kristen Buck taking the reins as CMO.
For slightly more than a year and a half, Buck was the SVP & chief of clinical development at Optum, part ... |
| 23.03.2020 | BELLUS Health buys IP rights, banishes royalties; AbbVie gets confirmatory data on accelerated AML drug | → Canada’s BELLUS Health $BLU has bagged the remaining IP rights for its BLU-5937 and related P2X3 antagonists. The deal scraps the tiered royalty payments that would have been due to adMare BioInnovations’ NEOMED Institut... |
| 20.02.2020 | The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| 11.02.2020 | Schrodinger raises $232M in IPO | Schrödinger sold a total of 13.6 million shares of common stock priced at $17 per share, with underwriters purchasing an additional 1.78 million shares. Its stock was listed on Nasdaq as SDGR on Feb. 6, trading just below $27 on Tuesday aft... |
| 03.12.2019 | Bright Angel Therapeutics Announces New Funding to Advance Therapies for Invasive Fungal Infections | TORONTO – Bright Angel Therapeutics, a biotechnology company focused on developing novel antifungal drugs, today announced an extension to their seed financing round, adding funding that will enable continued advancement of their lead progr... |
| 15.08.2019 | The Creation Of Biotech Startups: Evolution Not Revolution | The startup paradigm for the creation and funding of new biotech companies has evolved enormously over the past two decades. Recently there’s been a pair of articles from Tech VCs about applying alternative models of company creation (here,... |
| 21.05.2019 | Schrödinger Closes Financing Raising $110M | Schrödinger, a NYC-based provider of molecular modeling, drug design, and materials science software, completed the latest round with a total raise of $110m.
Backers included new investors Invus, Pavilion Capital, Oculus co-founder Michael ... |
| 20.05.2019 | Schrödinger raises more cash, amassing $110M for R&D drive | Schrödinger has raised more money, bringing the total size of its recent haul up to $110 million. The computing-enabled R&D shop will use the funds to advance its nascent pipeline of wholly owned drugs.
Sponsored by Agilent Technologies... |
| 20.05.2019 | Schrödinger raises more cash, amassing $110M for R&D drive | Schrödinger has raised more money, bringing the total size of its recent haul up to $110 million. The computing-enabled R&D shop will use the funds to advance its nascent pipeline of wholly owned drugs.
New York-based Schrödinger has mo... |
| 19.05.2019 | Schrodinger Closes $110M Financing | NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that several new investors have joined its latest funding round, which was completed with a total raise of $110 million to support continued advancement of the company’s industry-leadin... |
| 23.01.2019 | RNAi leader Alnylam inks collaboration pact with startup; GV's Rosana Kapeller joins Schrödinger board | → Eight months after putting together its $30 million A round, biotech startup CAMP4 has inked a new collaboration with RNAi trendsetter Alnylam. The two companies plan to work together to identify new drug targets for a... |
| 05.01.2019 | Schrödinger Closes $85 Million Financing | NEW YORK--(BUSINESS WIRE)--Schrödinger, a privately held company revolutionizing drug discovery through advanced molecular simulations, today announced the closing of an $85 million financing to support continued growth and innovation of it... |
| 04.01.2019 | Schrodinger Closes $85M Financing |
NEW YORK, NY, Schrodinger announced the closing of an $85 million financing.
>> Click here for more funding data on Schrodinger
>> To export Schrodinger funding data to PDF and Excel, click here
Schrodinger, a privately h... |
| 12.11.2013 | 18 hours, $33K, and 156,314 cores: Amazon cloud HPC hits a “petaflop” | One point twenty-one petaflops?!
Universal Pictures reader comments 54 with 48 posters participating
Share this story
Share on Facebook
Share on Twitter
Share on Reddit
What do you do if you need more than 150,000 CPU cores but don't have m... |
| 02.05.2012 | Amazon’s HPC cloud: supercomputing for the 99% | NASA's Pleiades supercomputer, seventh fastest in the world, uses a powerful InfiniBand interconnect.
Photograph by www.nasa.gov reader comments 20 with 14 posters participating, including story author
Share this story
Share on Facebook
Sha... |
| 19.04.2012 | $4,829-per-hour supercomputer built on Amazon cloud to fuel cancer research | Simulated images of compounds studied in pharmaceutical research reader comments 23 with 22 posters participating, including story author
Share this story
Share on Facebook
Share on Twitter
Share on Reddit
Cancer research is one of the last... |
| 28.06.2011 | Nimbus Discovery Closes $24M Series A Financing | Nimbus Discovery LLC, a biopharmaceutical company that is applying advances in computer-based drug discovery to develop new medicines against important drug targets, closed a $24m Series A financing.
The round was co-led by Atlas Venture, S... |
| 06.05.2010 | Schrödinger Receives Investment from Cascade | Schrödinger, Inc., a New York-based provider of chemical simulation for pharmaceutical and biotechnology research, has received an investment from Cascade Investment, L.L.C., a limited liability company wholly owned by William H. Gates III.... |
| - | Schrodinger raises $232M in IPO | Schrödinger, a little-known software company that helps some of the largest pharmaceutical brands with drug discovery, made its public debut. The company closed its initial public offering on Monday, raising a total of $232.3 million in pro... |
| - | Фонд семьи Гейтсов продал все акции Alibaba и Uber и увеличил долю в медицинском разработчике Schrodinger Статьи редакции... | Бумаги компании выросли примерно на 500% за год.
92 92 комментария
Форум
18 501 просмотров
Слушать
Траст, который управляет благотворительным фондом Билла и Мелинды Гейтс, провел ребалансировку инвестпортфеля, говорится в отчете за четверты... |
| - | Schrödinger to Present at the H.C. Wainwright Global Life Sciences Conference | NEW YORK--(BUSINESS WIRE)--Mar 1, 2021--
Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will provide a corporate overview ... |
| - | The evolution of New York City as a bioinnovation hub highlighted in new report | Three years ago, in its inaugural report on the venture capital landscape, New York City Health Business Leaders calculated that 79 startups and growth stage companies received $703 million in 2017. To put that in a national perspective, St... |
| - | Schrödinger: инвестиции в drug discovery и materials science. Есть ли перспективы после падения акций на 70%? | Для инвесторов в биотех и фармацевтические компании последний год выдался непростым. Популярный ETF SPDR S&P Biotech, он же XBI, состоящий в основном из биотехов малой и средней капитализации, потерял уже более 40% с пиковых значений в ... |
| - | Schrödinger raises $110m to develop drug discovery platform | - |
